Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Mohan

Showing results (751-760 of 781) with videos related to

Pageof 79
Sort By:
Journal of Medicinal Chemistry|December 20, 1996
2'-O-aminopropyl ribonucleotides: a zwitterionic modification that enhances the exonuclease resistance and biological activity of antisense oligonucleotidesR H Griffey, B P Monia, L L Cummins, et al.
Omics : a Journal of Integrative Biology|April 1, 2021
Proteomic Alterations Associated with Oral Cancer Patients with Tobacco Using HabitsFirdous Ahmad Bhat, Sonali V Mohan, Shankargouda Patil, et al.
Journal of General Internal Medicine|January 23, 2015
Increased cardiovascular disease, resource use, and costs before the clinical diagnosis of diabetes in veterans in the southeastern U.SDarin E Olson, Ming Zhu, Qi Long, et al.
Journal of Human Hypertension|August 1, 2014
Prevalence of and risk factors for hypertension in urban and rural India: the ICMR-INDIAB studyA Bhansali, V K Dhandania, M Deepa, et al.
Diabetes Research and Clinical Practice|April 22, 2021
Race/ethnicity and challenges for optimal insulin therapyNayla Cristina do Vale Moreira, Antonio Ceriello, Abdul Basit, et al.
Contemporary Clinical Trials|June 24, 2017
The INtegrating DEPrEssioN and Diabetes treatmENT (INDEPENDENT) study: Design and methods to address mental healthcare gaps in IndiaA J Kowalski, S Poongothai, L Chwastiak, et al.
Diabetes/Metabolism Research and Reviews|May 27, 2010
Does abnormal insulin action or insulin secretion explain the increase in prevalence of impaired glucose metabolism with age in populations of different ethnicities?F Ning, Q Qiao, J Tuomilehto, et al.
Genes and Immunity|October 16, 2004
The EIF2AK3 gene region and type I diabetes in subjects from South IndiaR A Allotey, V Mohan, M F McDermott, et al.
Microbiology Spectrum|February 24, 2022
Limited Recognition of Highly Conserved Regions of SARS-CoV-2Srividhya Swaminathan, Katie E Lineburg, George R Ambalathingal, et al.
Diabetes, Obesity & Metabolism|November 23, 2012
A multicentre, multinational, randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of gemigliptin (LC15-0444) in patients with type 2 diabetesS J Yang, K W Min, S K Gupta, et al.
Pageof 79

Showing results (751-760 of 781) with videos related to

Sort By:
Pageof 79
Journal of Medicinal Chemistry|December 20, 1996
2'-O-aminopropyl ribonucleotides: a zwitterionic modification that enhances the exonuclease resistance and biological activity of antisense oligonucleotidesR H Griffey, B P Monia, L L Cummins, et al.
Omics : a Journal of Integrative Biology|April 1, 2021
Proteomic Alterations Associated with Oral Cancer Patients with Tobacco Using HabitsFirdous Ahmad Bhat, Sonali V Mohan, Shankargouda Patil, et al.
Journal of General Internal Medicine|January 23, 2015
Increased cardiovascular disease, resource use, and costs before the clinical diagnosis of diabetes in veterans in the southeastern U.SDarin E Olson, Ming Zhu, Qi Long, et al.
Journal of Human Hypertension|August 1, 2014
Prevalence of and risk factors for hypertension in urban and rural India: the ICMR-INDIAB studyA Bhansali, V K Dhandania, M Deepa, et al.
Diabetes Research and Clinical Practice|April 22, 2021
Race/ethnicity and challenges for optimal insulin therapyNayla Cristina do Vale Moreira, Antonio Ceriello, Abdul Basit, et al.
Contemporary Clinical Trials|June 24, 2017
The INtegrating DEPrEssioN and Diabetes treatmENT (INDEPENDENT) study: Design and methods to address mental healthcare gaps in IndiaA J Kowalski, S Poongothai, L Chwastiak, et al.
Diabetes/Metabolism Research and Reviews|May 27, 2010
Does abnormal insulin action or insulin secretion explain the increase in prevalence of impaired glucose metabolism with age in populations of different ethnicities?F Ning, Q Qiao, J Tuomilehto, et al.
Genes and Immunity|October 16, 2004
The EIF2AK3 gene region and type I diabetes in subjects from South IndiaR A Allotey, V Mohan, M F McDermott, et al.
Microbiology Spectrum|February 24, 2022
Limited Recognition of Highly Conserved Regions of SARS-CoV-2Srividhya Swaminathan, Katie E Lineburg, George R Ambalathingal, et al.
Diabetes, Obesity & Metabolism|November 23, 2012
A multicentre, multinational, randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of gemigliptin (LC15-0444) in patients with type 2 diabetesS J Yang, K W Min, S K Gupta, et al.
Pageof 79